Vanguard Group Inc Taysha Gene Therapies, Inc. Transaction History

Vanguard Group Inc

$6.44 Trillion
Q3 2025

A detailed history of Vanguard Group Inc transactions in Taysha Gene Therapies, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 12,849,613 shares of TSHA stock, worth $47.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,849,613

Previous 10,894,127 17.95%

Holding current value

$47.8 Million

Previous $25.2 Million 60.84%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	BUY	$2.34 - $3.29 $4.58 Million - $6.43 Million	1,955,486 Added 17.95%	12,849,613 $40.5 Million
Q2 2025 Aug 11, 2025	BUY	$1.13 - $2.9 $2.4 Million - $6.16 Million	2,123,206 Added 24.21%	10,894,127 $25.2 Million
Q1 2025 May 09, 2025	SELL	$1.39 - $2.05 $188,821 - $278,478	-135,843 Reduced 1.53%	8,770,921 $12.2 Million
Q4 2024 Feb 11, 2025	BUY	$1.27 - $3.24 $814,457 - $2.08 Million	641,305 Added 7.76%	8,906,764 $15.4 Million
Q3 2024 Nov 13, 2024	BUY	$2.01 - $2.46 $2.21 Million - $2.7 Million	1,098,122 Added 15.32%	8,265,459 $16.6 Million
Q2 2024 Aug 13, 2024	BUY	$2.04 - $4.17 $2.55 Million - $5.21 Million	1,249,923 Added 21.12%	7,167,337 $16.1 Million
Q1 2024 May 10, 2024	SELL	$1.43 - $3.25 $397,758 - $903,997	-278,153 Reduced 4.49%	5,917,414 $17 Million
Q4 2023 Feb 14, 2024	BUY	$1.33 - $2.88 $1.15 Million - $2.5 Million	867,703 Added 16.29%	6,195,567 $11 Million
Q3 2023 Nov 14, 2023	BUY	$0.63 - $3.66 $2.36 Million - $13.7 Million	3,738,616 Added 235.24%	5,327,864 $16.8 Million
Q2 2023 Aug 14, 2023	BUY	$0.59 - $0.87 $3,427 - $5,054	5,810 Added 0.37%	1,589,248 $1.05 Million
Q1 2023 May 15, 2023	BUY	$0.65 - $2.3 $18,051 - $63,875	27,772 Added 1.79%	1,583,438 $1.27 Million
Q4 2022 Feb 10, 2023	BUY	$1.39 - $2.98 $673,960 - $1.44 Million	484,864 Added 45.28%	1,555,666 $3.52 Million
Q2 2022 Aug 12, 2022	BUY	$2.47 - $6.77 $144,835 - $396,979	58,638 Added 5.79%	1,070,802 $3.98 Million
Q1 2022 May 13, 2022	BUY	$5.22 - $11.86 $670,858 - $1.52 Million	128,517 Added 14.54%	1,012,164 $6.6 Million
Q4 2021 Feb 14, 2022	BUY	$11.43 - $19.2 $890,728 - $1.5 Million	77,929 Added 9.67%	883,647 $10.3 Million
Q3 2021 Nov 12, 2021	BUY	$15.82 - $21.57 $2.8 Million - $3.82 Million	177,074 Added 28.17%	805,718 $15 Million
Q2 2021 Aug 13, 2021	BUY	$19.29 - $26.38 $12.1 Million - $16.6 Million	628,644 New	628,644 $13.3 Million

Others Institutions Holding TSHA

# of Institutions

153

Shares Held

245M

Call Options Held

107K

Put Options Held

17K

View Full List

About Taysha Gene Therapies, Inc.

Ticker TSHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,359,500
Market Cap $180M
Description
Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for th...

More about TSHA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Taysha Gene Therapies, Inc. Transaction History